Policy interventions, including large-scale private-public partnerships, are key to reducing prescription drug shortages and averting patient harm. Shortages of prescription generic drugs, which ...
The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals. The actions represent the ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Today, the White House Office of National Drug Control Policy (ONDCP) is announcing the release of the Trump Administration’s Drug Policy Priorities, a comprehensive and coordinated blueprint to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback